{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:39:41Z","timestamp":1780450781223,"version":"3.54.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T00:00:00Z","timestamp":1643932800000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100013291","name":"European Observation Network for Territorial Development and Cohesion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013291","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.neuropharm.2021.108467","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T18:20:11Z","timestamp":1611858011000},"page":"108467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Exposure of R6\/2 mice in an enriched environment augments P42 therapy efficacy on Huntington's disease progression"],"prefix":"10.1016","volume":"186","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2248-1151","authenticated-orcid":false,"given":"Simon","family":"Couly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Carles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Denus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Benigno-Anton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9470-7853","authenticated-orcid":false,"given":"Florence","family":"Maschat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4074-6793","authenticated-orcid":false,"given":"Tangui","family":"Maurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2021.108467_bib1","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","article-title":"Anterograde transport of brain-derived neurotrophic factor and its role in the brain","volume":"389","author":"Altar","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108467_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mcn.2008.04.007","article-title":"CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6\/2 mice","volume":"39","author":"Apostol","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108467_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068775","article-title":"A huntingtin peptide inhibits polyQ-huntingtin associated defects","volume":"8","author":"Arribat","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2021.108467_bib4","first-page":"86","article-title":"Systemic delivery of P42 peptide: a new weapon to fight Huntington's disease","volume":"2","author":"Arribat","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neuropharm.2021.108467_bib5","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.neuropharm.2021.108467_bib6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fncel.2014.00254","article-title":"BDNF signaling and survival of striatal neurons","volume":"8","author":"Baydyuk","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108467_bib7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.semcdb.2011.07.002","article-title":"Effects of environmental enrichment and voluntary exercise on neurogenesis, learning and memory, and pattern separation: BDNF as a critical variable?","volume":"22","author":"Bekinschtein","year":"2011","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2021.108467_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020696","article-title":"Hdac6 knock-out increases tubulin acetylation but does not modify disease progression in the R6\/2 mouse model of Huntington's disease","volume":"6","author":"Bobrowska","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2021.108467_bib9","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease","volume":"24","author":"Canals","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108467_bib10","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108467_bib11","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003","article-title":"Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease","volume":"23","author":"Cepeda","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108467_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/gt.2015.113","article-title":"AAV1\/2-mediated BDNF gene therapy in a transgenic rat model of Huntington's disease","volume":"23","author":"Connor","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.neuropharm.2021.108467_bib13","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/hmg\/ddy207","article-title":"Improvement of BDNF signalling by P42 peptide in Huntington's disease","volume":"27","author":"Couly","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2021.108467_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.euroneuro.2020.08.010","article-title":"Sigma-1 (\u00cf\u01921) receptor activity is necessary for physiological brain plasticity in mice","volume":"39","author":"Crouzier","year":"2020","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2021.108467_bib15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.nlm.2018.02.014","article-title":"Topographical memory analyzed in mice using the Hamlet test, a novel complex maze","volume":"149","author":"Crouzier","year":"2018","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2021.108467_bib16","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1002\/cpmo.43","article-title":"Assessment of topographic memory in mice in a complex environment using the Hamlet test","volume":"8","author":"Crouzier","year":"2018","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"10.1016\/j.neuropharm.2021.108467_bib17","first-page":"1520","article-title":"Natural history of Huntington disease","volume":"70","author":"Dorsey","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neuropharm.2021.108467_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/0304-3940(92)90494-R","article-title":"Increased expression of brain-derived neurotrophic factor mRNA in rat hippocampus is associated with improved spatial memory and enriched environment","volume":"138","author":"Falkenberg","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2021.108467_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(00)02237-X","article-title":"Brain-derived neurotrophic factor in Huntington disease","volume":"866","author":"Ferrer","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2021.108467_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2021.108467_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/j.1471-4159.2007.05137.x","article-title":"Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice","volume":"105","author":"Gharami","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108467_bib22","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ab.2013.05.027","article-title":"Stain-Free total protein staining is a superior loading control to \u00ce\u00b2-actin for Western blots","volume":"440","author":"Gilda","year":"2013","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2021.108467_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1460-9568.2006.04590.x","article-title":"Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain","volume":"23","author":"Gin\u00e9s","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108467_bib24","doi-asserted-by":"crossref","first-page":"21537","DOI":"10.1074\/jbc.M109.084202","article-title":"Impaired TrkB-mediated ERK1\/2 activation in Huntington disease knock-in striatal cells involves reduced p52\/p46 Shc expression","volume":"285","author":"Gin\u00e9s","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2021.108467_bib25","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.neuroscience.2008.11.024","article-title":"Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseC\u00ce\u00b3 activity and glutamate receptor expression","volume":"158","author":"Giralt","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2021.108467_bib26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3389\/fnins.2017.00488","article-title":"Effects of environmental enrichment on doublecortin and BDNF expression along the dorso-ventral axis of the dentate gyrus","volume":"11","author":"Gualtieri","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108467_bib27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ana.10399","article-title":"Environmental enrichment reverses cognitive and molecular deficits induced by developmental lead exposure","volume":"53","author":"Guilarte","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108467_bib28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ab.2012.10.010","article-title":"Stain-Free technology as a normalization tool in Western blot analysis","volume":"433","author":"G\u00fcrtler","year":"2013","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2021.108467_bib29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.10094","article-title":"Environmental enrichment slows disease progression in R6\/2 Huntington's disease mice","volume":"51","author":"Hockly","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108467_bib30","first-page":"317","article-title":"On chorea","volume":"26","author":"Huntington","year":"1872","journal-title":"Medical and Surgical Reporter of Philadelphia"},{"key":"10.1016\/j.neuropharm.2021.108467_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/exnr.2000.7415","article-title":"Long-term environmental enrichment leads to regional increases in neurotrophin levels in rat brain","volume":"164","author":"Ickes","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108467_bib32","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108467_bib33","doi-asserted-by":"crossref","DOI":"10.1602\/neurorx.2.3.447","article-title":"The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies","volume":"2","author":"Li","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.neuropharm.2021.108467_bib34","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation","volume":"19","author":"Lione","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108467_bib35","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","article-title":"Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: parallel changes in muscle and brain","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2021.108467_bib36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijdevneu.2015.07.008","article-title":"Post-weaning environmental enrichment improves BDNF response of adult male rats","volume":"46","author":"Mosaferi","year":"2015","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108467_bib37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jcis.2015.06.010","article-title":"Development of pharmaceutical clear gel based on Peceol\u00ae, lecithin, ethanol and water: physicochemical characterization and stability study","volume":"457","author":"Mouri","year":"2015","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.neuropharm.2021.108467_bib38","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijpharm.2014.07.018","article-title":"Water solubilization capacity of pharmaceutical microemulsions based on Peceol\u00ae, lecithin and ethanol","volume":"475","author":"Mouri","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.neuropharm.2021.108467_bib39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijpharm.2016.01.072","article-title":"Formulation, physicochemical characterization and stability study of lithium-loaded microemulsion system","volume":"502","author":"Mouri","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.neuropharm.2021.108467_bib40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fncel.2016.00037","article-title":"Impaired TtrkbB signaling underlies reduced BDNF-mediated trophic support of striatal neurons in the R6\/2 mouse model of Huntington's disease","volume":"10","author":"Nguyen","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108467_bib41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng0793-221","article-title":"Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1","volume":"4","author":"Orr","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2021.108467_bib42","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s12035-019-01847-8","article-title":"Neuroprotective effects of doxycycline in the R6\/2 mouse model of Huntington's disease","volume":"57","author":"Paldino","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2021.108467_bib43","first-page":"8363274","article-title":"Modulation of phospho-CREB by systemically administered recombinant BDNF in the hippocampus of the R6\/2 mouse model of Huntington's dsease","author":"Paldino","year":"2019","journal-title":"Neurosci. J. 2019"},{"key":"10.1016\/j.neuropharm.2021.108467_bib44","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2014.05.032","article-title":"Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease","volume":"83","author":"Plotkin","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108467_bib45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.conb.2015.01.020","article-title":"Corticostriatal synaptic adaptations in Huntington's disease","volume":"33","author":"Plotkin","year":"2015","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2021.108467_bib46","article-title":"Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6\/2 mouse model of HD","volume":"8","author":"Rattray","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2021.108467_bib47","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.yexcr.2007.12.025","article-title":"Inhibition of endoplasmic reticulum stress counteracts neuronal cell death and protein aggregation caused by N-terminal mutant huntingtin proteins","volume":"314","author":"Reijonen","year":"2008","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.neuropharm.2021.108467_bib48","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1310-13.2013","article-title":"A small molecule TrkB ligand reduces motor impairment and neuropathology in R6\/2 and BACHD mouse models of Huntington's disease","volume":"33","author":"Simmons","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108467_bib49","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/jnc.14723","article-title":"Alterations in synaptic function and plasticity in Huntington disease","volume":"150","author":"Smith-Dijak","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108467_bib50","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.0953-816X.2004.03374.x","article-title":"Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6\/1 Huntington's disease transgenic mice","volume":"19","author":"Spires","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108467_bib51","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","article-title":"Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration","volume":"27","author":"Strand","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108467_bib52","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/35008142","article-title":"Delaying the onset of Huntington's in mice","volume":"404","author":"van Dellen","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108467_bib54","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/7449","article-title":"Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective","volume":"5","author":"Young","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2021.108467_bib55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3940(01)01837-7","article-title":"Enriched environment influences brain-derived neurotrophic factor levels in rat forebrain after focal stroke","volume":"305","author":"Zhao","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2021.108467_bib56","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821000216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821000216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:09:02Z","timestamp":1758438542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390821000216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":55,"alternative-id":["S0028390821000216"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108467","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exposure of R6\/2 mice in an enriched environment augments P42 therapy efficacy on Huntington's disease progression","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108467"}}